Covid-19 vaccine shows promising results in old patients: Moderna

Immune response in elderly similar to that seen in younger participants, says firm

Moderna on Wednesday said that an analysis of the early-stage data of its experimental Covid-19 vaccine showed that it induced immune responses in older adults that were similar to younger participants.

The drug developer is one of the leading US contenders in the race to develop a safe and effective vaccine against the novel coronavirus and its candidate, mRNA-1273, is already in the Phase 3 stage of human testing.

Moderna is now reporting interim data from the Phase 1 study, which includes new analysis from 20 additional people and details on how the vaccine performs in older people.

The analysis looked at 100